The Asepsis Transition: Infection Control Doctrine Before and After 1952
From The Long Sepsis, an encyclopedia of a world that didn't happen
The Asepsis Transition describes the period of institutional reorganization in medicine between roughly 1945 and 1960, during which infection control shifted from ad-hoc hospital procedures and regional variations into a formalized, internationally coordinated doctrine. The transition was not a sudden rupture but a recognition across the medical profession that bacterial infection without reliable systemic cure demanded wholesale institutional redesign. Its formal completion came at the Bacillary Congress of Geneva in 1952.
Before the Second World War, infection control in hospitals remained fragmentary. Surgeons in different nations and cities employed different standards of cleanliness, wound dressing, and isolation of infectious patients. The theory was familiar — that contamination caused infection — but implementation varied widely. Hospitals in major cities like Berlin and Paris had pioneered some standardized cleaning regimens, and military medical services had developed protocols for field wounds, yet these remained essentially local inventions. A surgeon in a provincial town hospital in 1938 worked under standards substantially different from those in a teaching hospital three hundred miles away. The azo drugs, available from the 1930s onward through Bayer AG and other manufacturers, offered hope that systemic bacterial infection might be chemically treatable, reducing the need for elaborate prevention. Few hospitals invested heavily in infrastructure designed purely to prevent what might soon be curable.
The 1943 Sicily campaign forced a brutal reckoning. Invasion casualties, particularly those with crush injuries and contaminated wounds, developed septicaemia and gangrene at rates that overwhelmed field hospitals and rear medical facilities. The azo drugs proved insufficient for systemic infections already established. Amputation rates climbed. Mortality from secondary infection became a tactical problem — it slowed casualty evacuation to rear hospitals, overloaded surgical resources, and kept men unable to return to combat. Military medical officers across the Allied services began compiling detailed records of wound infection outcomes, comparing the efficacy of different dressing materials, cleaning protocols, and isolation procedures. These were not academic questions. A reduction in infection-related casualties translated directly to unit strength and campaign tempo.
By 1945, as the war ended, a body of quantified evidence had accumulated showing that prevention through rigorous contamination control produced measurably better outcomes than reliance on chemical treatment after infection was established. The evidence was scattered across American, British, and Canadian military medical archives, and partly in Soviet records, but the pattern was consistent.
References
- 1.The Bacillary Congress of Geneva: Minutes and Recommendations]], Geneva Sanitary Bureau, 1952, p. 1-47
- 2.The Architecture of Prevention: Hospital Design and Infection Outcomes]], Richard Reinhardt, Archives of the Institute for the History of Bacteriology, Berlin, 1978, p. 156-203
- 3.Bacterial Genetics and the Limits of Chemical Therapy: A 1981 Retrospective]], Joshua Lederberg, Annual Review of Microbiology, 1981, vol. 35, p. 1-18
- 4.Postwar Institutional Memory And The Berlin Academy Of Sciences]], Institute for the History of Bacteriology Archive, MS. 447/1, 1989, p. 89-124